Related Experiment Video
Updated: Aug 6, 2026
08:32
Preparation of Pooled Human Platelet Lysate (pHPL) as an Efficient Supplement for Animal Serum-Free Human Stem Cell Cultures
Published on: October 30, 2009
Biotechnology: alternatives to human plasma-derived therapeutic proteins
1Division of Hematology, U.S. Food and Drug Administration, Rockville, MD, USA.
Bailliere'S Best Practice & Research. Clinical Haematology
|December 5, 2000
Summary
Therapeutic plasma proteins are evolving with biotechnology. Molecular biology offers recombinant alternatives and genetic engineering promises improved production and novel gene therapies for protein deficiencies.
Area of Science:
- Biotechnology
- Molecular Biology
- Protein Therapeutics
Background:
- Plasma-derived proteins have been vital therapeutics since the 1940s.
- Recent advances in molecular biology offer alternatives to natural plasma products.
Purpose of the Study:
- To explore the impact of molecular biology and genetic engineering on plasma protein therapeutics.
- To discuss the development of recombinant proteins, improved production systems, and gene therapy.
Main Methods:
- Review of advancements in recombinant DNA technology.
- Analysis of genetic engineering applications for protein modification and production.
- Exploration of gene therapy strategies for plasma protein deficiencies.
Main Results:
- Commercial availability of recombinant Factor VIII and Factor IX.
- Development of other recombinant plasma proteins.
- Emerging efficient production systems like transgenic plants and animals.
- Gene therapy as a potential permanent solution for protein deficiencies.
Conclusions:
- Biotechnology has revolutionized plasma protein therapy, offering recombinant alternatives and improved production methods.
- Genetic engineering and gene therapy hold promise for more accessible, cost-effective, and potentially curative treatments for plasma protein deficiencies.
Related Concept Videos
01:09Recombinant DNA
Overview
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.